Wolverine Trading, LLC Macrogenics Inc Put Options Transaction History

Wolverine Trading, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 12, 2021	SELL	$19.74 - $28.7 $175,686 - $255,430	-8,900 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$20.49 - $35.63 $63,518 - $110,453	-3,100 Reduced 25.83%	8,900 $238,000
Q1 2021 May 14, 2021	BUY	$18.99 - $33.2 $227,879 - $398,400	12,000 New	12,000 $373,000
Q3 2019 Nov 14, 2019	SELL	$12.44 - $17.48 $146,792 - $206,264	-11,800 Closed	0 $0
Q2 2019 Aug 20, 2019	SELL	$14.51 - $19.71 $40,628 - $55,188	-2,800 Reduced 19.18%	11,800 $200,000
Q1 2019 May 15, 2019	BUY	$11.11 - $25.6 $162,206 - $373,760	14,600 New	14,600 $263,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.